Cann Global Limited

ASX:CGB ISIN:AU0000038085

Cann Global Limited ASX:CGBCann Global Limited's (ASX:CGB) primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets.

Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group.

The Group also retains an interest in its existing Bauxite Projects.



Cann Global Limited (ASX:CGB) Quarterly Activities and Cashflow Report

🕔2/3/2020 8:18:29 AM 6378

Cann Global Limited (ASX:CGB) was pleased to announce a distribution agreement with Costco Australia for our premium quality certified organic hemp seed oil capsules in September.

Read Full Article

Cann Global Limited (ASX:CGB) New Costco and Epco Purchase Orders

🕔1/23/2020 8:24:07 AM 7147

The Board of Cann Global Limited (ASX:CGB) is pleased to provide an update on its recent exclusive distributorship supply contract deal signed with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam and its supply of T12 products to COSTCO Australia.

Read Full Article

Cann Global Limited (ASX:CGB) Strategic Landmark Cannabis Opportunity in South Africa

🕔12/19/2019 9:28:29 AM 6938

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it has entered into a Heads of Agreement with the South African company Koegas Medicinal Herbs (Pty) Ltd to establish a Joint Venture (CGB to hold 70%) in medicinal Cannabis production and distribution in Africa.

Read Full Article

Cann Global Limited (ASX:CGB) Secures Global Rights to Olivias Choice Formulas

🕔12/10/2019 9:20:47 AM 6355

Board of Cann Global Limited (ASX:CGB) is delighted to announce an agreement to secure the exclusive rights to the IP of the unique medicinal cannabis formulations that have been used by Olivia Newton John in her recent health challenge.

Read Full Article

Cann Global Limited (ASX:CGB) Operational Update

🕔12/6/2019 8:22:48 AM 9733

Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's operations of business for three of its divisions and its mining interest.

Read Full Article

Cann Global Limited (ASX:CGB) Chairperson's Address to 2019 AGM

🕔11/28/2019 2:55:41 PM 6891

Cann Global Limited (ASX:CGB) has been achieving significant milestones in these past 12 months. The most notable being the undertaking and successful completion of a very extensive and technically comprehensive re-compliance process

Read Full Article

Cann Global Limited (ASX:CGB) T12 Food Division Update

🕔11/11/2019 8:34:56 AM 4271

The Food management team at T12, are proud to announce the release of our new and nutritious 'Black Label' Hemp Seed Oil and Hemp Seed mixes product range for the discerning Australian and Asian consumer.

Read Full Article

Cann Global Limited (ASX:CGB) Institutional Investment to Support Expansion

🕔11/5/2019 9:46:44 AM 4146

Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has secured further institutional support from New York based L1 Capital Global Opportunities Master Fund ("L1" or "Investor"). The Company has agreed to issue 2,600,000 secured convertible notes (Notes) to raise $2.22M after costs.

Read Full Article

Cann Global Limited (ASX:CGB) September Quarterly Report

🕔11/1/2019 8:08:16 AM 4204

Cann Global Limited (ASX:CGB) presents its Quarterly report for the three months ended 30 September 2019.

Read Full Article

Cann Global Limited (ASX:CGB) Further Asian Business Expansion

🕔10/28/2019 8:31:39 AM 4287

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it is expanding the Company's current APAC/Asian presence and business activities, and has incorporated a further Asian focused subsidiary, Cann Global Asia Pty Ltd.

Read Full Article


  • This Page Viewed: (Last 7 Days: 158) (Last 30 Days: 568) (Since Published: 42480) 

Company Data

  • Level 21, 133 Castlereagh Street
    Sydney NSW 2023
  • Telephone
  • +61-2-8379-1832 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • E:

Company Reports

Latest Videos

Quarterly Report

Download Presentation

Social Media